» Articles » PMID: 33378496

Effect of Pharmacological Agents on Relapse Following Orthodontic Tooth Movement

Overview
Journal Angle Orthod
Specialty Dentistry
Date 2020 Dec 30
PMID 33378496
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate and synthesize systematically the evidence from animal studies pertaining to the effect of pharmacological agents on tooth movement relapse following cessation of orthodontic force application.

Materials And Methods: An electronic search was conducted in seven online databases (including gray sources) without restrictions until the third week of April 2019, followed by a hand search in the reference lists of eligible articles. Controlled animal studies investigating the effect of pharmacological agents on tooth movement relapse following orthodontic treatment were selected. Relevant data were extracted from eligible studies and the risk of bias assessment was done using SYRCLE's risk of bias tool. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation tool.

Results: The search identified 2354 records, of which 7 studies were deemed eligible for inclusion in the qualitative synthesis, with the majority presenting an unclear risk of bias. Orthodontic relapse was shown to decrease with the administration of pamidronate disodium, atorvastatin, aspirin, and chemically modified tetracycline-3. Inconsistent effects on relapse were observed after the use of simvastatin. The overall quality of retrieved evidence was assessed as low at best.

Conclusions: The available evidence shows that the investigated pharmacological agents may demonstrate variable effects on tooth movement relapse following cessation of orthodontic force. Additional evidence of higher quality is required to draw definitive conclusions on their effects and to make potential recommendations for clinical application.

Citing Articles

Effect of vitamin D deficiency on postorthodontic relapse: An animal study.

Khamees A, Al Groosh D Clin Exp Dent Res. 2023; 9(4):701-710.

PMID: 37448180 PMC: 10441610. DOI: 10.1002/cre2.765.


Orthodontic retention: what's on the horizon?.

Littlewood S, Dalci O, Dolce C, Holliday L, Naraghi S Br Dent J. 2021; 230(11):760-764.

PMID: 34117435 PMC: 8193167. DOI: 10.1038/s41415-021-2937-8.

References
1.
Rogers M . New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des. 2003; 9(32):2643-58. DOI: 10.2174/1381612033453640. View

2.
Kim T, Yoshida Y, Yokoya K, Sasaki T . An ultrastructural study of the effects of bisphosphonate administration on osteoclastic bone resorption during relapse of experimentally moved rat molars. Am J Orthod Dentofacial Orthop. 1999; 115(6):645-53. DOI: 10.1016/s0889-5406(99)70290-8. View

3.
Li H, Xia L, Wang S, Al-Balaa M, Liu W, Hua X . The expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in the compression area during orthodontic relapse. Eur J Orthod. 2019; 42(3):347-354. DOI: 10.1093/ejo/cjz046. View

4.
Liu L, Igarashi K, Haruyama N, Saeki S, Shinoda H, Mitani H . Effects of local administration of clodronate on orthodontic tooth movement and root resorption in rats. Eur J Orthod. 2004; 26(5):469-73. DOI: 10.1093/ejo/26.5.469. View

5.
Vieira G, Chaves S, Ferreira V, Freitas K, Amorim R . The effect of simvastatin on relapse of tooth movement and bone mineral density in rats measured by a new method using microtomography. Acta Cir Bras. 2015; 30(5):319-27. DOI: 10.1590/S0102-865020150050000003. View